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Effects of dietary protein restriction on hemodynamics in chronic renal
failure. To elucidate the effect of protein and phosphorus restriction on
hemodynamics in chronic renal failure, 14 patients were placed on a
low-protein very-low-phosphorus diet (LPVLPD) and observed for
metabolic and hemodynamic changes. For three weeks after initiation
of the LPVLPD, the patients displayed a positive sodium balance in
spite of dietary sodium restriction. During the fourth week, sodium
balance decreased and approached zero. Sodium retention was accom-
panied by a significant decrease in plasma renin activity (P < 0.05) and
mean blood pressure (P < 0.01), an increase in body weight (P < 0.05),
a slight temporary decrease in hemoglobin (P < 0.05), hematocrit (P <
0.05) and total protein (P < 0.005), a negative nitrogen balance, and an
increase in left ventricular ejection fraction (P < 0.01) and peak filling
rate (P < 0.05). Serum creatinine concentration and endogenous
creatinine clearance did not change during the experiment. These data
indicate a role of dietary protein and phosphorus restriction in cardiac
and fluid homeostasis in the pathophysiology of chronic renal failure.
Interest has recently focused on the role of dietary therapy in
chronic renal failure because dietary protein restriction has
profound effects on both the healthy and diseased kidney. For
example, restricting dietary protein in experimental renal insuf-
ficiency appears to prevent sclerosing glomerulopathy [1], and
accumulating lines of evidence suggest that in patients with
chronic renal failure protein restriction diminishes the level of
proteinuria [2], alleviates progressive azotemia, and may slow
or halt the progression of chronic renal insufficiency [3—5],
although its efficacy on the prevention of progression has yet to
be established [6].
Previous studies on the abnormalities of body fluid and
sodium status revealed that extracellular fluid volume is either
normal or elevated in patients with chronic renal failure [7—9].
However, methodologic problems associated with the measure-
ments of extracellular fluid have raised doubts about these
results [10]. Furthermore, it remains unknown whether protein
restriction has any effect on the putative deregulation of fluid
and sodium states in chronic renal failure.
The present study is designed to determine the short-term
effect of protein and phosphorus restriction on sodium balance
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and systemic hemodynamics in non-oliguric patients with
chronic renal failure.
Methods
Patients
Fourteen consecutive patients with mild to moderate chronic
renal failure (9 men and 5 women) who had been maintained on
an unrestricted diet were studied. Their ages were from 49 to 83
years, averaging 58.9 2.6 years (mean SEM). Renal disease
diagnosis was based on clinical signs, laboratory tests and, in
four patients, a renal biopsy. The diagnoses were distributed as
follows: chronic glomerulonephritis, five; diabetic nephropa-
thy, three; polycystic kidney disease, two; chronic pyelonephri-
tis, one; and unknown, three. Serum creatinine was between
2.2 and 13.3 mg/dl, averaging 6.66 0.98 mg/dl. Chronic renal
failure was defined as a sustained increase in serum creatinine
concentration or decreased endogenous creatinine clearance for
more than six months. Patients with clinical signs and a history
of congestive heart failure, cardiac valve disease, ischemic
heart disease, cardiomyopathy, cerebrovascular accident, se-
vere hypertension, malignancy, or renal obstruction were ex-
cluded from the study. Patients showing edema or requiring
either diuretic medication or immediate dialysis were also
excluded. Eight patients received daily antihypertensive ther-
apy: one received 20 mg nifedipine, one received 40 mg
nifedipine, two received 60 mg nifedipine, one received 1 mg
prazosin hydrochloride, one received 40 mg nicardipine, one
received 10 mg carteolol hydrochloride, one received a combi-
nation of 750 mg methyldopa and 60 mg nicardipine, and none
had their treatment modified during the study period. No other
medicine other than multivitamin tablets was given for the
duration of the study except for three patients who received
allopurinol and three who received minor tranquilizers. In-
formed consent was obtained from each patient prior to entry
into the study.
All patients were admitted to the metabolic ward during the
entire five-week study period and began with a sodium-re-
stricted diet for one week. Their diet was then changed to four
weeks of the LPVLPD which contained 30 g protein, 350 mg
phosphorus and 5 g sodium chloride per day. They also partic-
ipated in an intensive dietary education program as described
previously [11]. Each individual's food intake was assessed
using a dietary record sheet that listed the specific composition
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Table 1. Average daily dietary ingestion of protein, phosphorus, energy, and sodium during the LPVLPD in 14 patients with chronic renal
failure
Control
Week
1 2 3 4
Protein g/day 66.7 3.2 29.6 1.1 29.5 1.1 29.8 1.1 29.5 1.2
Phosphorus mg/day 970 48 335 12 335 11 339 12 331 12
Energy kcal/day 1837 46 1851 44 1890 31 1901 30 1883 29
Sodium mEqlday 102.0 7.2 96.7 7.7 98.3 7.3 95.2 7.5 95.3 7.6
Values are given as mean SEM.
of each food item. Nutritionists used this dietary record sheet to
record the percentage of each food item actually ingested by the
patient by weighing served and uneaten food. The composition
of ingested food portions was calculated with reference to the
Standard Tables of Food Composition in Japan (Science and
Technology Agency, Prime Minister's Office, 4th ed.). In order
to motivate and encourage patients to adhere to the LPVLPD,
each patient completed a complementary dietary record sheet
which was evaluated by nutritionists throughout the entire
study period. All discrepancies between the dietary record
sheet and the nutritionists' weighed record were closely exam-
ined so that each patient could understand their inaccuracy and
further discuss the diet. Complete 24-hour urine samples were
collected every day for the five week study period. Following
an overnight fast and recumbency at 7:00 a.m., blood samples
were obtained when the diet was changed to the LPVLPD and
every week after initiation of the LPVLPD. A complete blood
count was performed and the plasma was analyzed for the
concentration of sodium, potassium, chloride, urea, creatinine,
uric acid, protein, albumin, calcium, phosphate, aldosterone,
and renin activity. Plasma renin activity and plasma aldosterone
concentration were measured by radioimmunoassay. The 24-
hour urine collections were analyzed for sodium, chloride,
urea, creatinine, protein, and phosphate. Sodium balance was
calculated daily during the LPVLPD. Nitrogen balance (Bn)
was calculated daily using the equation as described by Mitch et
al [6, 12]: Bn = In — U — NUN, where In is nitrogen intake (as
measured by the weighed food record), U is the urea nitrogen
appearance rate (the sum of urinary urea nitrogen, urinary
protein and the change in urea nitrogen pool), and NUN is
non-urea nitrogen excretion. Blood pressure was measured
with a sphygmomanometer every day at 06:00, 14:00 and 19:00
hours. The mean blood pressure was calculated as the sum of
the diastolic blood pressure and one third of the pulse pressure.
Equilibrium-gated radionuclide ventriculography was per-
formed on patients resting in the supine position the day before
and three weeks after initiation of the LPVLPD using red blood
cells labeled with 925 MBq of mTchuman serum albumin.
Images were acquired using a wide field cardiac gamma camera
oriented in the modified left anterior oblique projection with a
caudal tilt to best isolate the left ventricle. Electrocardiographic
gating was used to collect and organize the data into a series of
32 frames per cardiac cycle and to obtain a high-resolution left
ventricular time activity curve. A least-squares smoothing
algorithm produced a time activity curve, which was subse-
quently used to calculate the ejection fraction and indices of
diastolic filling. The peak filling rate was defined as the maxi-
mum rate of count increase during diastole and was expressed
as the fraction of end-systolic counts. The time from end systole
to the point of peak filling rate was measured to give the time to
peak filling rate.
Statistical analyses were performed using analysis of vari-
ance and the Friedman rank test. Differences in ejection frac-
tion, peak filling rate and time to peak filling rate from values
before and after the LPVLPD were analyzed using either a
paired t-test or Wilcoxon's test for paired data. Results are
expressed as mean SEM.
Results
The average daily ingestion of protein, phosphorus, calories,
and sodium of 14 patients before and during the LPVLPD were
measured (Table 1). After initiation of the LPVLPD, serum
urea nitrogen underwent a marked reduction from the baseline
level of 58.6 6.2 to 43.1 4.8 mg/dl by the end of the fourth
week (P < 0.005) while serum phosphate decreased from 4.10
0.34 to 3.67 0.24 mg/dl (P < 0.05). Serum albumin and
creatinine did not change significantly. Serum total protein,
hemoglobin and hematocrit showed a slight, temporary de-
crease during the second and third weeks (Table 2). Endoge-
nous creatinine clearance calculated from a complete 48-hour
urine collection did not change significantly during the experi-
ment (15.5 3.1 mLlmin/1.73 m2 at baseline and 15.9 3.1
mlJminIl .73 m2 by the end of the fourth week). Average daily
sodium balance was positive during the initial two weeks and
decreased to near zero during the fourth week (Table 3).
Average daily sodium retention during the first two weeks was
12.5 mEq/day. Body weight increased by an average of 1.2 kg
after four weeks. Plasma renin activity was normal at 1.56
0.30 nglmllhr prior to the LPVLPD and decreased to 0.66
0.18 nglmllhr after four weeks (normal 0.8 to 4.4 nglmllhr, Table
2). Plasma aldosterone concentration did not show any statis-
tical change during the LPVLPD (normal, 2 to 13 ng/dl, Table
2). Nitrogen balance was negative during the initial two week
period following the initiation of the LPVLPD and approached
zero during the third week (Table 3). Left ventricular ejection
fraction and peak filling rate significantly increased from 75.0
3.7% and 2.06 0.23 EDV/sec, respectively, at baseline to 83.0
3.3% and 2,70 0.21 EDV/sec after the third week (Table 4).
The basal resting heart rate of 73.8 1.9 beats/mm did not
change, nor did the time to peak filling rate. Average mean
blood pressure showed a slight but significant decrease after
three weeks (Table 2).
Discussion
Nutritional measurements during this study confirmed a
satisfactory compliance with our dietary regimen throughout
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Table 2. Changes in clinical and biochemical parameters in patients with chronic renal failure
Days
Variable 0 7 14 21 28
Body weight kg 57.0 1.5 57.5 1.6 57.9 1.7 57.9 l.7 58.2 l.7a
Mean blood pressure mm Hg 109.2 4.3 108.3 3.5 107.7 4.5 104.3 3.6a 103.2 3,8b
P.asma renin activity ng/ml/hr 1.56 0.30 0.84 0.23a 0.90 0.24a 0.85 0.66 0.18
Plasma aldosterone concentration ng/dl 10.6 1.4 10.9 1.4 9.7 1.5 9.9 1.3 10.6 1.6
Serum total protein g/dl 6.47 0.17 6.41 0.19 6.28 0.18C 6.35 0.20k 6.41 0.19
Serum albumin g/dI 3.70 0.15 3.73 0.13 3.65 0.15 3.69 0.13 3.75 0.11
Serum creatinine mg/dl 6.66 0.98 6.64 0.96 6.50 0.95 6.34 0.93 6.37 0.96
Serum urea nitrogen mg/dl 58.6 6.2 50.7 5.6c 46.1 5.1 45.4 47C 43.1 4.8C
Serum calcium mg/dl 8.87 0.13 8.89 0.18 8.70 0.09 8.96 0.08 8.95 0.09
Serum phosphate mg/dl 4.10 0.34 3.75 0.20a 3.74 0.20a 3.58 0.20C 3.67 0.24
Hemoglobin gIdi 10.14 0.69 9.97 0.65 9.76 0.61a 9.78 0.58a 9.80 0.60
Hematocrit % 31.3 2.1 30.9 1.9 30.2 1.7k 30.0 l.8 30.3 1.7
Values given as mean SEM.
a P < 0.05, "P < 0.01, C P < 0.005
Table 3. Sodium balance, nitrogen balance, and urinary urea nitrogen during the LPVLPD
Week
1 2 3 4
Sodium balance mEqiday 11.12 2.53 13.89 3.35 3.98 3.12 0.26 5.68
Nitrogen balance mg/day —626 301 —73 327 22 255 41 264
Urinary urea nitrogen mg/day 3646 228 3192 260 3131 263 3061 261
Table 4. Cardiac response in chronic renal failure as determined by
radionuclide ventriculography
Baseline 3 week P value
HR min' 73.8 1.9 77.5 4.0 NS
EF % 75.0 3.7 83.0 3.3 <0.01
PFR ED V/sec 2.06 0.23 2.70 0.21 <0.05
TPFR sec 0.26 0.01 0.21 0.01 NS
Values are given as mean SEM. Abbreviations are: HR, heart rate;
EF, ejection fraction; PFR, left ventricular peak filling rate; EDV, end
diastolic volume; TPFR, time to peak filling rate; NS, not significant.
the study period with an average daily protein, phosphorus,
caloric, and sodium ingestion of 29.6 g, 335 mg, 1881 kcal, and
96.1 mEq, respectively. During the LPVLPD there was very
little change in sodium and calorie intake when compared to the
amount taken prior to the LPVLPD. In contrast, protein and
phosphorus intake decreased dramatically during the LPVLPD
(Table 1). It should be noted that our patients participated in
daily meetings in which a health care team consisting of
doctors, nutritionists and nurses educated them in the funda-
mental concepts and basis of the protein-restricted diet and
encouraged them to strictly adhere to the LPVLPD. In addi-
tion, all 14 patients were admitted during the entire five week
period and underwent metabolic and hemodynamic studies
under the intensive observation of the health care team.
Our remarkable finding was that following initiation of the
LPVLPD, patients developed significant sodium retention de-
spite concurrent dietary sodium restriction, Of interest in this
regard is that sodium retention also develops in rats placed on
a low-protein diet [13], and in patients with Kwashiorkor. Since
our patients were not in such a severe state of malnutrition,
they showed only an initial, temporary sodium retention of a
few weeks duration following initiation of the LPVLPD. We
have followed our patients who adhered to the LPVLPD for at
least six months and none of them showed any evidence
suggesting continued sodium and fluid retention nor any signs of
malnutrition. We note here, however, that a diet containing less
than 0.6 g protein/kg/day should be either avoided or prescribed
with extreme caution, since the long-term safety of any such
diet has yet to be established.
It should be emphasized that patients with any sign of local or
systemic edema were carefully excluded from participation in
the present study. Therefore, any change in body weight may
reflect changes of extracellular fluid volume and lean body mass
and not those of third space fluctuations. Total sodium retention
following initiation of the LPVLPD was 204.8 mEq for four
weeks and should have increased extracellular fluid volume by
approximately 1.4 liters if other parameters remained constant,
whereas actual body weight gain during the same period was 1.2
kg. Following introduction of the LPVLPD, patients displayed
a temporary negative nitrogen balance while retaining sodium.
This metabolic change may account for the slight difference
between theoretical and actual body weight gain.
We have recently reported that patients with non-insulin
dependent diabetes mellitus and chronic renal failure showed a
negative nitrogen balance during the first three weeks of the
LPVLPD [11]. In both normal subjects and patients with renal
failure, a negative nitrogen balance has been reported during
the first week of protein restriction [14]. These findings are
further verified by our present metabolic data showing an initial
temporary negative nitrogen balance of two weeks in duration,
which suggest that a negative nitrogen balance immediately
following restriction of protein and phosphorus cannot predict
the patients' future nutritional status.
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Radionuclide ventriculography revealed a significantly in-
creased ejection fraction and left ventricular peak filling rate
after three weeks, suggesting improved left ventricular systolic
and diastolic function. These data are also consistent with an
expansion in extracellular fluid volume. Extracellular fluid
volume expansion is further supported by the findings that
temporary decreases in hemoglobin, hematocrit, and total pro-
tein, and a sustained reduction in plasma renin activity coin-
cided with the development of a significant positive sodium
balance. Extracellular fluid volume expansion and the subse-
quent increase in ejection fraction is frequently associated with
enhanced net cardiac output in the absence of cardiac valvular
diseases or significant stroke volume changes. In the present
study, although cardiac output was not directly measured, the
results of radionuclide ventriculography suggest that net car-
diac output increased during the LPVLPD. The combination of
increased net cardiac output with lowered mean blood pressure
suggests a decrease in total peripheral vascular resistance.
However, extrarenal vasodilation with compensatory sodium
retention, circulating volume expansion and the subsequent
increase in cardiac output is probably not the primary mecha-
nism for the hemodynamic changes observed in the present
study because the concurrent decrease in plasma renin activity
cannot be explained. A more plausible explanation is that the
LPVLPD directly caused both a significant retention of sodium
and a putative decrease in total peripheral resistance, which
subsequently resulted in extracellular fluid volume expansion,
suppressed plasma renin activity, and improved ejection frac-
tion.
The mechanism(s) for the positive sodium balance following
the LPVLPD remain(s) unknown. Changes in total protein and
hematocrit values were too small to alter either the plasma
colloid pressure and viscosity [15] or the Starling forces regu-
lating tubular reabsorption of sodium chloride. Although so-
dium chloride reabsorption in the proximal tubule is secondary
to the reabsorption of bicarbonate, correction of metabolic
acidosis is an unlikely cause for the sodium retention because
neither blood pH nor bicarbonate concentration changed during
the LPVLPD [11]. On the other hand, azotemia increases the
load of filtered urea and impermeable anions per remaining
functioning nephron, resulting in increased obligatory sodium
excretion via osmotic diuresis [16, 17]. If salt wastage of
chronic renal failure is caused by osmotic diuresis [7], salt
wastage can be reversed by dietary protein and phosphorus
restriction. Parathyroid hormone may also play a role in sodium
retention since parathyroid hormone significantly inhibits so-
dium and fluid reabsorption in the proximal tubule [181. Al-
though not measured in this study, parathyroid hormone levels
may reasonably be expected to decrease after the LPVLPD,
resulting in sodium retention.
Dietary protein is known to exert profound effects on the
renin-angiotensin-aldosterone axis. A high-protein diet is ac-
companied by an elevated plasma renin activity both in rats and
in patients with chronic renal failure [19, 20], whereas protein
restriction suppresses the renin-angiotensin-aldosterone system
[20, 21]. Our results show that plasma renin activity decreased
concurrently with the development of extracellular fluid volume
expansion and thus suggest for the first time a role of the renal
baroreceptor in the release of renin during protein and phos-
phorus restriction.
In summary, dietary protein and phosphorus restriction are
responsible for temporary sodium retention and subsequent
changes in cardiac hemodynamics in patients with chronic renal
failure. We conclude that dietary protein and phosphorus may
play very significant roles in the hemodynamic regulation of
chronic renal insufficiency.
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